post in-lin result mark solid perform pharmaci
pressur flat same-stor script digit invest store reposit
healthcar partnership remain focu compani look build
capabilities/servic cash flow remain solid compani
announc share repurchas dividend bump environ
remain challeng view risk/reward balanc reiter
hold trim pt pt ep
revenu in-lin ep net revenu in-lin
estim fuel strength pharmaci usa busi benefit
continu share gain bp driven contribut
central specialti growth script volum grew ss
volum roughli flat overal script volum shi
lower script off-set better expect revenu per script overal
us pharmaci sale came modestli ahead sale retail side
increas ss sale tie on-going focu
profit growth beauti health segment continu enjoy gain
despit bp improv pharmaci usa sg revenu
oper margin came bp lower estim
off-set interest tax result ep four cent ahead
estim
test store partnership focu creat customiz dynam
walgreen store remain high compani continu expand/develop
pilot market gainsvil addit trial market kansa citi
pilot new partnership hold provid
primari care clinic supplement urgent cares/drop clinic gear toward
senior popul addit continu think number
recent partnership carri promis labcorp medexpress would expect
continu expans given patient conveni provid prefer
treatment lower cost site care
technolog invest continu make progress further
digit capabl launch find digit navig health
servic avail walgreen mobil app websit
addit work continu updating/modern compani oper
model suppli chain system think improv effici
drive cost save increas sophistication/transpar improv custom
tr target
satisfact lastli compani digit offer take hold million download
mobil app retail script initi digit channel
capit deploy conjunct earn announc share
repurchas program increas quarterli dividend absent sizabl
share buyback expect take place next year program expir
date cffo strong come roughli line
expect addit compani rais low end full year ep guidanc
 adjust ep unchang
updat integr acquir store track number convers
walgreen store format current trial addit part store optim
program store close custom success transfer pharmaci
retail pharmaci wholesal retail pharmaci post revenu
in-lin expect result part driven fx benefit cc basi
ss sale fell ss pharmaci sale ss retail sale declin market
condit remain challeng due lower prescript volum reduc govern fund
pharmaci wholesal revenu touch ahead estim ss sale
increas cc bit manag expect tough oper condit hand
continent european countri off-set solid result emerg market uk
page
revenu
revenu
revenu
net incom
non-gaap add back tax
adjust net incom
page
inc global leader pharmaceut servic industri
store sizabl wholesale/distribut network countri compani largest retail
pharmaci unit state retail pharmaci usa divis gener total
compani revenu remain sale come retail intern pharmaci
revenu wholesal revenu
bullish underli trend pharmaceut servic expect sever tailwind
age popul util growth increas gener penetr growth specialti drive on-going
growth sector forese futur believ recent format sever strateg
partnership optum prime demonstr valu compani scale/cap
provid near term volum tailwind reason optim challeng exist
 retail pharmaci busi continu see margin pressur tie sever factor
rate price pressur payer contract increasingli difficult overal retail environ
valuat risk
hold rate price target base stock trade adjust
cash ep roughli line current multipl view compani scale
key differenti expect on-going benefit deal like compani free cash
flow gener view risk/reward balanc given us pharmaci margin pressur
like linger difficult retail environ upsid risk price target includ better
synergi captur stronger core trend dissip pbm margin pressur aggress capit
deploy downsid risk includ issu integr increas price pressur addit
compani mention note
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
